These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16140964)

  • 1. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival.
    Lou Y; Vitalis TZ; Basha G; Cai B; Chen SS; Choi KB; Jeffries AP; Elliott WM; Atkins D; Seliger B; Jefferies WA
    Cancer Res; 2005 Sep; 65(17):7926-33. PubMed ID: 16140964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival.
    Lou Y; Basha G; Seipp RP; Cai B; Chen SS; Moise AR; Jeffries AP; Gopaul RS; Vitalis TZ; Jefferies WA
    Clin Cancer Res; 2008 Mar; 14(5):1494-501. PubMed ID: 18316574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.
    Corrias MV; Occhino M; Croce M; De Ambrosis A; Pistillo MP; Bocca P; Pistoia V; Ferrini S
    Tissue Antigens; 2001 Feb; 57(2):110-7. PubMed ID: 11260505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors.
    Qin Z; Harders C; Cao X; Huber C; Blankenstein T; Seliger B
    Cancer Res; 2002 May; 62(10):2856-60. PubMed ID: 12019164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity.
    Tao J; Li Y; Liu YQ; Wang L; Yang J; Dong J; Wu Y; Shen GX; Tu YT
    J Invest Dermatol; 2008 Aug; 128(8):1991-6. PubMed ID: 18385764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
    Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
    Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAP expression provides a general method for improving the recognition of malignant cells in vivo.
    Alimonti J; Zhang QJ; Gabathuler R; Reid G; Chen SS; Jefferies WA
    Nat Biotechnol; 2000 May; 18(5):515-20. PubMed ID: 10802618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.
    Johnsen AK; Templeton DJ; Sy M; Harding CV
    J Immunol; 1999 Oct; 163(8):4224-31. PubMed ID: 10510359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocytes express abundant surface class I MHC and efficiently use transporter associated with antigen processing, tapasin, and low molecular weight polypeptide proteasome subunit components of antigen processing and presentation pathway.
    Chen M; Tabaczewski P; Truscott SM; Van Kaer L; Stroynowski I
    J Immunol; 2005 Jul; 175(2):1047-55. PubMed ID: 16002705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-γ enhances the anti-tumour immune response of dendritic cells against oral squamous cell carcinoma.
    Wei H; Hongya P; Linlin J; Mujiang A; Kuijie W; Duohong Z; Qingang H; Zhiyuan Z
    Arch Oral Biol; 2011 Sep; 56(9):891-8. PubMed ID: 21474117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?
    Mehling M; Simon P; Mittelbronn M; Meyermann R; Ferrone S; Weller M; Wiendl H
    Acta Neuropathol; 2007 Aug; 114(2):111-9. PubMed ID: 17541610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells.
    Whiteside TL; Stanson J; Shurin MR; Ferrone S
    J Immunol; 2004 Aug; 173(3):1526-34. PubMed ID: 15265880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
    Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
    Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
    Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S
    Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.
    Doyle A; Martin WJ; Funa K; Gazdar A; Carney D; Martin SE; Linnoila I; Cuttitta F; Mulshine J; Bunn P
    J Exp Med; 1985 May; 161(5):1135-51. PubMed ID: 2580935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines.
    Seliger B; Schreiber K; Delp K; Meissner M; Hammers S; Reichert T; Pawlischko K; Tampé R; Huber C
    Tissue Antigens; 2001 Jan; 57(1):39-45. PubMed ID: 11169257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines.
    Palmisano GL; Contardi E; Morabito A; Gargaglione V; Ferrara GB; Pistillo MP
    Hum Immunol; 2005 Jan; 66(1):1-12. PubMed ID: 15620456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.